MDR Reporting Timeline under 21 CFR Part 803

1. Key takeaways

Under the reporting matrix of 21 CFR 803.10, manufacturers must report deaths, serious injuries, and malfunctions within 30 calendar days of becoming aware of the event; for events that require remedial action, or events that FDA has requested be reported, the deadline is 5 working days. User facilities must report deaths within 10 working days. These three deadlines correspond to different reporting entities and different event types, and they run in parallel rather than replacing one another. A company that assumes a single uniform reporting period for all Medical Device Reporting obligations will systematically misjudge its deadlines, particularly for the shorter working-day clocks that leave far less room for internal review than the calendar-day obligations. Map every obligation onto the correct clock at the moment an event is received; this is the first control that determines whether the rest of the MDR process can succeed.

2. Legal basis

The Medical Device Reporting framework is built from the following provisions of Title 21 of the Code of Federal Regulations, all of which remain in force as of the verification date noted at the end of this page.

3. Expert insights

Insight one: MDR deadlines form a matrix, not a single number.

Under 21 CFR 803.10, the reporting deadline is determined by the combination of the reporting entity (manufacturer, importer, or user facility) and the event type (death, serious injury, malfunction, or event requiring remedial action). Describing MDR deadlines as a uniform 30 days is inaccurate. The correct practical estimate is built entity by entity and event type by event type, because each combination carries its own clock. Any training material, standard operating procedure, or internal guidance that states a single deadline for all MDR reports should be corrected before it causes a missed filing. In our practical estimate, the matrix itself should be the first document a new market-entry team reads, because every downstream decision about event intake and triage depends on which clock applies.

Insight two: the difference between calendar days and working days materially compresses the available time.

The manufacturer deadline for deaths, serious injuries, and malfunctions is 30 calendar days; for events requiring remedial action or requested by FDA it is 5 working days. The latter amounts to a practical estimate of roughly 5 to 7 calendar days in real time. The speed demanded of internal processes is therefore far higher for the working-day deadlines than for the calendar-day ones. An investigation-and-decision workflow that is comfortable for a 30-day clock will not fit inside a 5-working-day window without a dedicated fast-track path that shortens the steps between awareness of the event and submission of the report. The two clocks also interact: an event may start on the calendar-day track and later require remedial action, at which point the working-day deadline takes over and the remaining calendar time is irrelevant.

Insight three: manufacturers also carry an annual reporting obligation.

Under 21 CFR 803.56, manufacturers must submit an annual report (Form FDA 3419) before January 1 of each year. This is a periodic obligation that stands independently of individual event reports. It is easy to overlook precisely because it does not arise from any specific adverse event: no single incident triggers it, and a year with few or no reportable events still ends with the same annual filing duty. Treating it as a recurring calendar commitment rather than an event-driven one is the reliable way to keep it current. Assigning the filing to a named owner with a December reminder is a simple control that prevents the obligation from being discovered only after the deadline has passed.

Insight four: the form and format of reports are prescribed by regulation.

Under the relevant provisions of 21 CFR Part 803, mandatory reports use Form FDA 3500A. FDA also operates the eMDR (electronic Medical Device Reporting) channel for electronic submission. Companies should determine their submission method according to their own circumstances and keep it consistent, because a submission channel that is chosen ad hoc for each event introduces avoidable variation at the most deadline-sensitive moment in the MDR process. Whichever channel is selected, the completed forms and their submission confirmations should be retained, pending verification at each audit that every report can be traced from event awareness to filing.

4. Practical recommendations

• Create an entity-by-event-type deadline matrix and post it in the quality and customer service departments.
• Set up a dedicated fast-track process with a 5-working-day clock for events requiring remedial action.
• Schedule the annual report (Form FDA 3419) as a fixed work item every December.
• Use Form FDA 3500A or eMDR, and determine the submission method according to the company situation.
• Archive all individual event reports and annual reports, retaining traceable records that link each filing to the underlying event record.

5. Verification checklist

• □ A deadline matrix listing entity by event type has been created and distributed
• □ The 30 calendar day process for manufacturer reports of deaths, serious injuries, and malfunctions has been established
• □ The 5 working day fast track for events requiring remedial action or requested by FDA has been established
• □ The annual report (Form FDA 3419) has been scheduled as a December work item each year
• □ The submission method, Form FDA 3500A or eMDR, has been determined
• □ All reporting records have been archived

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, US Agent and local testing support for the United States market. Our team manages FDA establishment registration and listing, 510(k)/De Novo/PMA submissions, and supports post-market reporting obligations. Business enquiries: info@grzanglobal.com